Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lane

Showing results (851-860 of 1,271) with videos related to

Pageof 128
Sort By:
The Journal of Biological Chemistry|January 7, 2018
Tumor stressors induce two mechanisms of intracellular P-glycoprotein-mediated resistance that are overcome by lysosomal-targeted thiosemicarbazonesLina Al-Akra, Dong-Hun Bae, Sumit Sahni, et al.
Cancer|June 22, 2010
Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapyBrian R Lane, Armine K Smith, Benjamin T Larson, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 2026
Inhibition of equilibrative nucleoside transporters 1 and 2 by proteolysis-targeting chimeras (PROTACs)Patricia A Vignaux, Lucy J Martinez Guerrero, Renuka Raman, et al.
The Journal of Urology|January 15, 2013
Differential use of partial nephrectomy for intermediate and high complexity tumors may explain variability in reported utilization ratesBrian R Lane, Shay Golan, Scott Eggener, et al.
Communicable Diseases Intelligence (2018)|March 18, 2019
Recent trends in invasive group A Streptococcus disease in VictoriaJane Oliver, Mathilda Wilmot, Janet Strachan, et al.
Pharmacological Research|August 31, 2015
The renaissance of polypharmacology in the development of anti-cancer therapeutics: Inhibition of the "Triad of Death" in cancer by Di-2-pyridylketone thiosemicarbazonesPatric J Jansson, Danuta S Kalinowski, Darius J R Lane, et al.
BJU International|September 25, 2018
Pathological upgrading at radical prostatectomy for patients with Grade Group 1 prostate cancer: implications of confirmatory testing for patients considering active surveillanceDeborah R Kaye, Ji Qi, Todd M Morgan, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|August 24, 2022
A Letter to Your Care Providers: Implementation and Analysis of a Letter-based Advance Care Planning Initiative for Gynecologic Oncology PatientsCatherine N Zivanov, Anne Coogan, Robin R Lane, et al.
Cell Reports Sustainability|September 15, 2025
Barriers to quantifying human alterations of global floodplains and how we can overcome themAdnan Rajib, Charles R Lane, Ryan R Morrison, et al.
JAMA Network Open|July 15, 2024
Surgeon Skill and Perioperative Outcomes in Robot-Assisted Partial NephrectomyYuzhi Wang, Samantha Wilder, Mahmoud Hijazi, et al.
Pageof 128

Showing results (851-860 of 1,271) with videos related to

Sort By:
Pageof 128
The Journal of Biological Chemistry|January 7, 2018
Tumor stressors induce two mechanisms of intracellular P-glycoprotein-mediated resistance that are overcome by lysosomal-targeted thiosemicarbazonesLina Al-Akra, Dong-Hun Bae, Sumit Sahni, et al.
Cancer|June 22, 2010
Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapyBrian R Lane, Armine K Smith, Benjamin T Larson, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 2026
Inhibition of equilibrative nucleoside transporters 1 and 2 by proteolysis-targeting chimeras (PROTACs)Patricia A Vignaux, Lucy J Martinez Guerrero, Renuka Raman, et al.
The Journal of Urology|January 15, 2013
Differential use of partial nephrectomy for intermediate and high complexity tumors may explain variability in reported utilization ratesBrian R Lane, Shay Golan, Scott Eggener, et al.
Communicable Diseases Intelligence (2018)|March 18, 2019
Recent trends in invasive group A Streptococcus disease in VictoriaJane Oliver, Mathilda Wilmot, Janet Strachan, et al.
Pharmacological Research|August 31, 2015
The renaissance of polypharmacology in the development of anti-cancer therapeutics: Inhibition of the "Triad of Death" in cancer by Di-2-pyridylketone thiosemicarbazonesPatric J Jansson, Danuta S Kalinowski, Darius J R Lane, et al.
BJU International|September 25, 2018
Pathological upgrading at radical prostatectomy for patients with Grade Group 1 prostate cancer: implications of confirmatory testing for patients considering active surveillanceDeborah R Kaye, Ji Qi, Todd M Morgan, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|August 24, 2022
A Letter to Your Care Providers: Implementation and Analysis of a Letter-based Advance Care Planning Initiative for Gynecologic Oncology PatientsCatherine N Zivanov, Anne Coogan, Robin R Lane, et al.
Cell Reports Sustainability|September 15, 2025
Barriers to quantifying human alterations of global floodplains and how we can overcome themAdnan Rajib, Charles R Lane, Ryan R Morrison, et al.
JAMA Network Open|July 15, 2024
Surgeon Skill and Perioperative Outcomes in Robot-Assisted Partial NephrectomyYuzhi Wang, Samantha Wilder, Mahmoud Hijazi, et al.
Pageof 128